Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New location sections were added for California, Illinois, Massachusetts, New York, and Nouvelle-Aquitaine and old location sections were removed; the revision updated from v3.3.2 to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T21:27:35.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision updated to v3.3.2 (replacing v3.2.0) on the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T13:48:00.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The funding status disclaimer that warned about updates and operating status was removed. The page now solely presents the study details and related information.
    Difference
    0.2%
    Check dated 2025-11-18T07:21:28.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Updated the Locations entry to replace 'Tainan City, Taiwan, 70403' with 'Tainan, Taiwan, 70403'.
    Difference
    0.0%
    Check dated 2025-11-11T03:03:11.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    No significant content changes were detected; observed differences appear to be minor formatting adjustments that do not affect the study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:25:21.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Dates were added (extending the timeline to 2025–2027) while older dates were removed. This indicates an update to the time-related content without changing core information.
    Difference
    0.3%
    Check dated 2025-10-20T17:10:16.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.